Alemtuzumab (CAMPATH 1-H) therapy in sporadic inclusion body myositis (sIBM) Alters disease progression and suppresses endomysial inflammation

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Dalakas, MC; Rakocevic, G; McElroy, B; Salaftheh, MK; Schmidt, J; Harris-Love, M; Shrader, J; Levy, E; Kirk, AD

Published Date

  • January 1, 2007

Published In

Volume / Issue

  • 62 /

Start / End Page

  • S60 - S61

Published By

Pages

  • 2

International Standard Serial Number (ISSN)

  • 0364-5134

Conference Name

  • 132nd Annual Meeting of the American-Neurological-Association

Conference Location

  • Washington, DC

Conference Start Date

  • October 7, 2007

Conference End Date

  • October 10, 2007